Balboa Wealth Partners

Position in GILD — Gilead Sciences, Inc.

CIK 1929008 SCOTTSDALE, AZ

Position in GILD

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$220,084

-$205,970 QoQ

Shares Held

1,742

-43.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#1,867

of 2,266 holders

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Balboa Wealth Partners holds $9,778,849 across 9 Drug Manufacturers - General names. GILD ranks #8 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	10,057	$2,530,743
2	JNJ	Johnson & Johnson	9,731	$2,471,382
3	LLY	ELI LILLY & Co	1,478	$1,772,757
4	MRK	Merck & Co., Inc.	6,729	$864,676
5	NVO	Novo Nordisk A S	15,451	$740,720
6	PFE	Pfizer Inc	26,316	$633,689
7	AMGN	Amgen Inc	907	$328,442
8	GILD	Gilead Sciences, Inc. This page	1,742	$220,084

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$220,084	1,742	-43.0%	Shares	Sole	2026-08-10
2026-03-31	$426,054	3,057	+2.7%	Shares	Sole	2026-04-16
2025-12-31	$365,519	2,978	+42.7%	Shares	Sole	2026-01-16
2025-03-31	$233,848	2,087	-40.6%	Shares	Sole	2025-04-23
2024-03-31	$257,400	3,514	-1.8%	Shares	Defined	2024-05-13
2023-12-31	$290,015	3,580	-6.9%	Shares	Defined	2024-02-09
2023-09-30	$288,294	3,847	-10.4%	Shares	Defined	2023-10-23
2023-06-30	$330,938	4,294	-25.7%	Shares	Defined	2023-08-08
2023-03-31	$479,649	5,781	-10.7%	Shares	Defined	2023-05-12
2022-12-31	$556,050	6,477	-70.6%	Shares	Defined	2023-02-14
2022-09-30	$1,360,696	22,057	—	Shares	Sole	2023-01-04
No filing history on record for this holder in this stock.